11/7
08:36 am
chrs
Coherus BioSciences, Inc. (NASDAQ: CHRS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
Medium
Report
Coherus BioSciences, Inc. (NASDAQ: CHRS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
11/7
02:31 am
chrs
Coherus BioSciences Inc (CHRS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ... [Yahoo! Finance]
Medium
Report
Coherus BioSciences Inc (CHRS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ... [Yahoo! Finance]
11/6
07:28 pm
chrs
Coherus BioSciences (CHRS) Reports Q3 Loss, Tops Revenue Estimates [Yahoo! Finance]
Medium
Report
Coherus BioSciences (CHRS) Reports Q3 Loss, Tops Revenue Estimates [Yahoo! Finance]
11/6
04:13 pm
chrs
Coherus BioSciences Reports Third Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
Coherus BioSciences Reports Third Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
11/6
04:01 pm
chrs
Coherus BioSciences Reports Third Quarter 2024 Financial Results and Provides Business Update
Medium
Report
Coherus BioSciences Reports Third Quarter 2024 Financial Results and Provides Business Update
11/5
08:22 am
chrs
Coherus BioSciences Inc (CHRS) Q3 2024: Everything You Need to Know Ahead of Earnings [Yahoo! Finance]
Medium
Report
Coherus BioSciences Inc (CHRS) Q3 2024: Everything You Need to Know Ahead of Earnings [Yahoo! Finance]
10/30
04:20 pm
chrs
Coherus to Report Third Quarter 2024 Financial Results on November 6, 2024
Low
Report
Coherus to Report Third Quarter 2024 Financial Results on November 6, 2024
10/19
02:07 am
chrs
Coherus BioSciences, Inc. (NASDAQ: CHRS) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Low
Report
Coherus BioSciences, Inc. (NASDAQ: CHRS) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
10/11
11:09 pm
chrs
Coherus BioSciences, Inc. (NASDAQ: CHRS) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Medium
Report
Coherus BioSciences, Inc. (NASDAQ: CHRS) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
9/20
06:47 am
chrs
Institutional owners may take dramatic actions as Coherus BioSciences, Inc.'s (NASDAQ:CHRS) recent 12% drop adds to one-year losses [Yahoo! Finance]
Medium
Report
Institutional owners may take dramatic actions as Coherus BioSciences, Inc.'s (NASDAQ:CHRS) recent 12% drop adds to one-year losses [Yahoo! Finance]
9/16
08:03 am
chrs
Coherus BioSciences, Inc. (NASDAQ: CHRS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
High
Report
Coherus BioSciences, Inc. (NASDAQ: CHRS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
9/6
11:07 pm
chrs
Coherus BioSciences, Inc. (NASDAQ: CHRS) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Medium
Report
Coherus BioSciences, Inc. (NASDAQ: CHRS) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
9/6
06:34 am
chrs
Age-related Macular Degeneration Digital Marketing Trends Report 2024: Metrics of Pharma Assets in AMD Including Branded Websites for Patients and HCPs and Unbranded Sites [Yahoo! Finance]
Medium
Report
Age-related Macular Degeneration Digital Marketing Trends Report 2024: Metrics of Pharma Assets in AMD Including Branded Websites for Patients and HCPs and Unbranded Sites [Yahoo! Finance]
8/31
12:06 am
chrs
Junshi Biosciences Announces 2024 Interim Financial Results and Provides Corporate Updates [Financial Post (Toronto, Ontario, Canada)]
Low
Report
Junshi Biosciences Announces 2024 Interim Financial Results and Provides Corporate Updates [Financial Post (Toronto, Ontario, Canada)]
8/31
12:00 am
chrs
Junshi Biosciences Announces 2024 Interim Financial Results and Provides Corporate Updates [Yahoo! Finance]
Low
Report
Junshi Biosciences Announces 2024 Interim Financial Results and Provides Corporate Updates [Yahoo! Finance]
8/29
11:08 pm
chrs
Coherus BioSciences, Inc. (NASDAQ: CHRS) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Low
Report
Coherus BioSciences, Inc. (NASDAQ: CHRS) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.